healthcare triangle inc - HCTI

HCTI

Close Chg Chg %
0.78 -0.03 -3.86%

Open Market

0.75

-0.03 (3.86%)

Volume: 103.28K

Last Updated:

Sep 9, 2026, 12:09 PM EDT

Company Overview: healthcare triangle inc - HCTI

HCTI Key Data

Open

$0.81

Day Range

0.73 - 0.81

52 Week Range

0.77 - 223.20

Market Cap

$11.83M

Shares Outstanding

14.97M

Public Float

14.07M

Beta

1.09

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$65.59

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.53M

 

HCTI Performance

1 Week
 
-0.37%
 
1 Month
 
-36.98%
 
3 Months
 
-64.67%
 
1 Year
 
-99.49%
 
5 Years
 
N/A
 

HCTI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About healthcare triangle inc - HCTI

Healthcare Triangle, Inc. operates as a healthcare information technology company, which engages in advancing various solutions for the cloud services, data science, and professional and managed services sectors for the healthcare and life sciences industry. It operates through the following segments: Software Services, Managed Services and Support, and Platform Services. The Software Services segment focuses on the sale of software services that are generated from providing strategic advisory, implementation, and development services. The Managed Services and Support segment includes post implementation support and cloud hosting. The Platform services segment offers solutions under CloudEz, DataEz, and Readabl.AI. The company was founded by Suresh Venkatachari and Keith T. Ryan on October 29, 2019 and is headquartered in Pleasanton, CA.

HCTI At a Glance

Healthcare Triangle, Inc.
7901 Stoneridge Drive
Pleasanton, California 94588
Phone 1-925-270-4812 Revenue 13.89M
Industry Information Technology Services Net Income -9,476,000.00
Sector Technology Services 2025 Sales Growth 18.767%
Fiscal Year-end 12 / 2026 Employees 84
View SEC Filings

HCTI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.169
Price to Book Ratio 2.123
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1.415
Enterprise Value to Sales 0.926
Total Debt to Enterprise Value 0.835

HCTI Efficiency

Revenue/Employee 165,369.048
Income Per Employee -112,809.524
Receivables Turnover 6.711
Total Asset Turnover 0.973

HCTI Liquidity

Current Ratio 1.028
Quick Ratio 1.028
Cash Ratio 0.596

HCTI Profitability

Gross Margin 8.531
Operating Margin -70.47
Pretax Margin -68.217
Net Margin -68.217
Return on Assets -66.352
Return on Equity -389.398
Return on Total Capital -45.738
Return on Invested Capital -389.398

HCTI Capital Structure

Total Debt to Total Equity 107.574
Total Debt to Total Capital 51.825
Total Debt to Total Assets 40.362
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital N/A
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Healthcare Triangle Inc - HCTI

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
45.89M 33.20M 11.70M 13.89M
Sales Growth
+30.10% -27.64% -64.77% +18.77%
Cost of Goods Sold (COGS) incl D&A
37.97M 27.99M 9.70M 12.71M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
3.37M 1.57M 889.00K 705.00K
Depreciation
35.00K 48.00K 32.00K 13.00K
Amortization of Intangibles
3.34M 1.52M 857.00K 692.00K
COGS Growth
+45.07% -26.27% -65.37% +31.06%
Gross Income
7.92M 5.21M 2.00M 1.19M
Gross Income Growth
-12.96% -34.20% -61.60% -40.78%
Gross Profit Margin
+17.26% +15.69% +17.11% +8.53%
2022 2023 2024 2025 5-year trend
SG&A Expense
18.34M 11.20M 6.75M 10.97M
Research & Development
5.95M 799.00K 429.00K 536.00K
Other SG&A
12.38M 10.40M 6.32M 10.44M
SGA Growth
+26.82% -38.94% -39.69% +62.53%
Other Operating Expense
- - - -
-
Unusual Expense
(1.08M) 1.71M (7.00K) (41.00K)
EBIT after Unusual Expense
(9.34M) (7.70M) (4.74M) (9.75M)
Non Operating Income/Expense
- - 12.00K 839.00K
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
212.00K 968.00K 1.21M 567.00K
Interest Expense Growth
-62.59% +356.60% +25.31% -53.26%
Gross Interest Expense
212.00K 968.00K 1.21M 567.00K
Interest Capitalized
- - - -
-
Pretax Income
(9.55M) (8.65M) (5.96M) (9.48M)
Pretax Income Growth
-61.11% +9.39% +31.14% -59.07%
Pretax Margin
-20.81% -26.05% -50.93% -68.22%
Income Tax
- 63.00K 35.00K 12.00K
Income Tax - Current - Domestic
- 63.00K 35.00K 12.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(9.61M) (8.69M) (5.97M) (9.48M)
Minority Interest Expense
- - - -
-
Net Income
(9.61M) (8.69M) (5.97M) (9.48M)
Net Income Growth
-61.51% +9.61% +31.28% -58.75%
Net Margin Growth
-20.94% -26.16% -51.03% -68.22%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(9.61M) (8.69M) (5.97M) (9.48M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(9.61M) (8.69M) (5.97M) (9.48M)
EPS (Basic)
-39077.064 -31051.5948 -16895.0484 -153.1554
EPS (Basic) Growth
-29.36% +20.54% +45.59% +99.09%
Basic Shares Outstanding
245.92135176699998 279.72824596839996 353.29939714799997 61.87K
EPS (Diluted)
-39077.064 -31051.5948 -16895.0484 -153.1554
EPS (Diluted) Growth
-29.36% +20.54% +45.59% +99.09%
Diluted Shares Outstanding
245.92135176699998 279.72824596839996 353.29939714799997 61.87K
EBITDA
(7.04M) (4.42M) (3.86M) (9.08M)
EBITDA Growth
-78.85% +37.25% +12.60% -135.21%
EBITDA Margin
-15.35% -13.31% -33.02% -65.39%

Snapshot

Average Recommendation BUY Average Target Price 5.00
Number of Ratings 1 Current Quarters Estimate -0.97
FY Report Date 09 / 2026 Current Year's Estimate -10.23
Last Quarter’s Earnings -1.56 Median PE on CY Estimate N/A
Year Ago Earnings -44.58 Next Fiscal Year Estimate -3.18
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate -0.97 -0.87 -10.23 -3.18
High Estimates -0.97 -0.87 -10.23 -3.18
Low Estimate -0.97 -0.87 -10.23 -3.18
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Healthcare Triangle Inc in the News